Literature DB >> 28602166

Mast cells in breast cancer angiogenesis.

Anca Maria Cimpean1, Roberto Tamma2, Simona Ruggieri3, Beatrice Nico3, Alina Toma1, Domenico Ribatti4.   

Abstract

Mast cells, accumulate in the stroma surrounding certain tumors and take part to the inflammatory reaction occurring at the periphery of the tumor. Mast cell-secreted angiogenic cytokines facilitate tumor vascularization not only by a direct effect but also by stimulating other inflammatory cells of the tumor microenvironment to release other angiogenic mediators. An increased number of mast cells have been demonstrated in angiogenesis associated with solid tumors, including breast cancer. Mast cells might act as a new target for the adjuvant treatment of breast cancer through the selective inhibition of angiogenesis, tissue remodeling and tumor promoting molecules, allowing the secretion of cytotoxic cytokines and preventing mast cell mediated immune-suppression.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Angiogenesis; Anti-angiogenesis; Breast cancer; Mast cells; Tumor growth

Mesh:

Year:  2017        PMID: 28602166     DOI: 10.1016/j.critrevonc.2017.04.009

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  21 in total

1.  Mast Cells as an Indicator and Prognostic Marker in Molecular Subtypes of Breast Cancer.

Authors:  Ecaterina Carpenco; Raluca Amalia Ceauşu; Anca Maria Cimpean; Puşa Nela Gaje; Lilian Șaptefraţi; Veaceslav Fulga; Valeriu David; Marius Raica
Journal:  In Vivo       Date:  2019 May-Jun       Impact factor: 2.155

2.  Poor Response to Neoadjuvant Chemotherapy Correlates with Mast Cell Infiltration in Inflammatory Breast Cancer.

Authors:  Naoto T Ueno; Savitri Krishnamurthy; Jennifer A Wargo; Elizabeth A Mittendorf; Sangeetha M Reddy; Alexandre Reuben; Souptik Barua; Hong Jiang; Shaojun Zhang; Linghua Wang; Vancheswaran Gopalakrishnan; Courtney W Hudgens; Michael T Tetzlaff; James M Reuben; Takahiro Tsujikawa; Lisa M Coussens; Khalida Wani; Yan He; Lily Villareal; Anita Wood; Arvind Rao; Wendy A Woodward
Journal:  Cancer Immunol Res       Date:  2019-05-01       Impact factor: 11.151

Review 3.  Mast cells and angiogenesis in pancreatic ductal adenocarcinoma.

Authors:  Vito Longo; Roberto Tamma; Oronzo Brunetti; Salvatore Pisconti; Antonella Argentiero; Nicola Silvestris; Domenico Ribatti
Journal:  Clin Exp Med       Date:  2018-02-28       Impact factor: 3.984

Review 4.  Proteomics and its applications in breast cancer.

Authors:  Anca-Narcisa Neagu; Danielle Whitham; Emma Buonanno; Avalon Jenkins; Teodora Alexa-Stratulat; Bogdan Ionel Tamba; Costel C Darie
Journal:  Am J Cancer Res       Date:  2021-09-15       Impact factor: 5.942

5.  Mast Cells Interact with Endothelial Cells to Accelerate In Vitro Angiogenesis.

Authors:  Devandir Antonio de Souza Junior; Vivian Marino Mazucato; Ana Carolina Santana; Constance Oliver; Maria Celia Jamur
Journal:  Int J Mol Sci       Date:  2017-12-13       Impact factor: 5.923

Review 6.  Crosstalk between Tumor-Infiltrating Immune Cells and Cancer-Associated Fibroblasts in Tumor Growth and Immunosuppression of Breast Cancer.

Authors:  Jarupa Soongsathitanon; Pranisa Jamjuntra; Nuttavut Sumransub; Supaporn Yangngam; Marjorie De la Fuente; Glauben Landskron; Peti Thuwajit; Marcela A Hermoso; Chanitra Thuwajit
Journal:  J Immunol Res       Date:  2021-07-13       Impact factor: 4.818

7.  A Phase II Clinical Trial of Pembrolizumab and Enobosarm in Patients with Androgen Receptor-Positive Metastatic Triple-Negative Breast Cancer.

Authors:  Yuan Yuan; Jin Sun Lee; Susan E Yost; Paul H Frankel; Christopher Ruel; Colt A Egelston; Weihua Guo; John D Gillece; Megan Folkerts; Lauren Reining; Sarah K Highlander; Kim Robinson; Simran Padam; Norma Martinez; Aileen Tang; Daniel Schmolze; James Waisman; Mina Sedrak; Peter P Lee; Joanne Mortimer
Journal:  Oncologist       Date:  2020-11-24       Impact factor: 5.837

Review 8.  Targeting VEGF/VEGFR to Modulate Antitumor Immunity.

Authors:  Ju Yang; Jing Yan; Baorui Liu
Journal:  Front Immunol       Date:  2018-05-03       Impact factor: 7.561

Review 9.  Harnessing the immune system in the battle against breast cancer.

Authors:  Elizabeth S Nakasone; Sara A Hurvitz; Kelly E McCann
Journal:  Drugs Context       Date:  2018-02-12

Review 10.  Unraveling the Role of Angiogenesis in Cancer Ecosystems.

Authors:  Iratxe Zuazo-Gaztelu; Oriol Casanovas
Journal:  Front Oncol       Date:  2018-07-02       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.